Product NDC: | 24623-001 |
Proprietary Name: | Advanced Protection |
Non Proprietary Name: | OCTINOXATE and Zinc Oxide |
Active Ingredient(s): | .075; .05 g/g; g/g & nbsp; OCTINOXATE and Zinc Oxide |
Administration Route(s): | TOPICAL |
Dosage Form(s): | CREAM |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24623-001 |
Labeler Name: | CBI Laboratories, Inc |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part352 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20010825 |
Package NDC: | 24623-001-20 |
Package Description: | 56.7 g in 1 TUBE (24623-001-20) |
NDC Code | 24623-001-20 |
Proprietary Name | Advanced Protection |
Package Description | 56.7 g in 1 TUBE (24623-001-20) |
Product NDC | 24623-001 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | OCTINOXATE and Zinc Oxide |
Dosage Form Name | CREAM |
Route Name | TOPICAL |
Start Marketing Date | 20010825 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | CBI Laboratories, Inc |
Substance Name | OCTINOXATE; ZINC OXIDE |
Strength Number | .075; .05 |
Strength Unit | g/g; g/g |
Pharmaceutical Classes |